The U.S. Food and Drug Administration has approved the first over-the-counter continuous glucose monitor.
The Dexcom Stelo Glucose Biosensor System will be available by summer for people with prediabetes or Type 2 diabetes who are not using insulin to manage their condition.
How It Works
The Dexcom system is intended for people aged 18 and older who rely on oral medication to treat their diabetes and are looking for more information on how diet and exercise impact blood sugar levels. However, the FDA said that the system is not designed for people with problematic hypoglycemia, which is low blood sugar, as it does not alert users to this potentially dangerous condition.
A.C. Dahnke
Author
A.C. Dahnke is a freelance writer and editor residing in California. She has covered community journalism and health care news for nearly a decade, winning a California Newspaper Publishers Award for her work.
